← FDA Drug Approvals (Drugs@FDA)

ARIPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: VISTAPHARM LLC · Approved 2019-12-26

Drug application

FDA Application #
ANDA212870
Application type
Abbreviated New Drug Application (Generic)
Brand name
ARIPIPRAZOLE
Generic name
ARIPIPRAZOLE
Active ingredients
ARIPIPRAZOLE
Dosage form
SOLUTION
Route
ORAL
Marketing status
Prescription
Sponsor
VISTAPHARM LLC
Manufacturer
VistaPharm, LLC
First approval
2019-12-26

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown